Cigna Corporation (CI) Holdings Boosted by Advisor Group Inc.

Advisor Group Inc. boosted its stake in Cigna Corporation (NYSE:CI) by 13.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 4,386 shares of the health services provider’s stock after purchasing an additional 510 shares during the period. Advisor Group Inc.’s holdings in Cigna were worth $819,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Cigna by 40.8% during the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after purchasing an additional 1,184,632 shares in the last quarter. FMR LLC grew its stake in shares of Cigna by 6.7% during the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after purchasing an additional 432,978 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Cigna by 4,082.8% during the second quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock worth $73,355,000 after purchasing an additional 427,754 shares in the last quarter. Vanguard Group Inc. lifted its position in Cigna by 2.5% in the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after acquiring an additional 424,469 shares during the last quarter. Finally, American Century Companies Inc. lifted its position in Cigna by 56.9% in the second quarter. American Century Companies Inc. now owns 1,140,341 shares of the health services provider’s stock valued at $190,882,000 after acquiring an additional 413,759 shares during the last quarter. Hedge funds and other institutional investors own 87.85% of the company’s stock.

Shares of Cigna Corporation (NYSE CI) traded up $1.79 during trading on Thursday, hitting $206.00. 980,132 shares of the stock were exchanged, compared to its average volume of 1,352,227. The company has a current ratio of 0.39, a quick ratio of 0.39 and a debt-to-equity ratio of 0.37. Cigna Corporation has a twelve month low of $131.03 and a twelve month high of $212.46. The firm has a market capitalization of $50,325.72, a price-to-earnings ratio of 19.67, a price-to-earnings-growth ratio of 1.56 and a beta of 0.50.

Cigna (NYSE:CI) last issued its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, topping the consensus estimate of $2.36 by $0.47. Cigna had a net margin of 5.74% and a return on equity of 18.85%. The company had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same period in the prior year, the business posted $1.94 earnings per share. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. equities analysts forecast that Cigna Corporation will post 10.34 EPS for the current fiscal year.

CI has been the subject of a number of research reports. Royal Bank Of Canada reissued an “outperform” rating and issued a $220.00 price target (up from $185.00) on shares of Cigna in a research report on Friday, November 3rd. Jefferies Group boosted their price target on shares of Cigna from $221.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Zacks Investment Research cut shares of Cigna from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $191.00 target price on shares of Cigna in a report on Sunday, September 17th. Finally, Credit Suisse Group initiated coverage on shares of Cigna in a report on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 target price for the company. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Cigna currently has an average rating of “Buy” and a consensus target price of $201.50.

In other news, Director William D. Zollars sold 1,232 shares of the stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total value of $230,667.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here. Insiders sold 36,203 shares of company stock worth $7,211,251 over the last quarter. Company insiders own 1.30% of the company’s stock.

WARNING: “Cigna Corporation (CI) Holdings Boosted by Advisor Group Inc.” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/07/cigna-corporation-ci-shares-bought-by-advisor-group-inc.html.

Cigna Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply